Journal News

From the journals: MCP

Sarah May
Sept. 2, 2021

Discovering drugs in deadly venom. Improving transplant outcomes with better storage. Linking mannose glycosylation to eye development. Read about papers on these topics recently published in the journal Molecular & Cellular Proteomics.

Drug discovery from deadly venom

The purple cone snail, Conus purpurascens, hunts fish and uses venom to immobilize its prey. Cone snail venom contains diverse toxic peptides, or conopeptides, that are biologically active, target-specific and valuable for drug discovery. One of the most powerful known painkillers, ziconotide, marketed as Prialt, was derived from a conopeptide.

FTJ-MCP-9-2-21-445x297.jpg
Alex Holt/NIST
A purple cone snail uses its harpoon to pierce through a latex-covered tube,
allowing a researcher to collect its venom.

Conopeptides vary among the more than 800 cone snail species and among members of the same species. Even a single cone snail specimen can produce unique conopeptide cocktails, called cabals, specialized for predation or defense. Cone snails also can hypermodify conopeptides at the post-translational step, increasing the diversity of the toxins and extending their range of biological targets. The extreme diversity of conopeptides provides a rich source of biologically active molecules for drug discovery.

In a recent study in the journal Molecular & Cellular Proteomics, Meghan Grandal and colleagues at the National Institute of Standards and Technology collected and analyzed the injected venom from 27 specimens of the purple cone snail. Using high-resolution mass spectrometry techniques, they discovered 543 unique conopeptides derived from 33 base peptide sequences — 21 of which were newly identified base peptides. An abundant and newly discovered conopeptide named PVIIIA illustrates the complexity and diversity of modifications to the base conopeptide that occur among various purple cone snail specimens. Building on previous studies, the researchers showed that the different snail specimens produce one of two unique venom cocktails. These two cocktails correspond to what are known as the “lightning strike cabal” that rapidly induces paralysis of the snail’s prey and the “motor cabal” that acts more slowly to induce irreversible paralysis.

Knowing which conopeptides are co-expressed within a specific cocktail will give the researchers important clues as to the possible neural targets of newly identified conopeptides. This will be a critical step in developing new conopeptides into neural probes or therapeutics.

 

How better storage improves transplant outcomes

The demand for kidney transplants exceeds the supply of available kidneys. Some donated kidneys go unused, however, due to the prolonged time between circulatory arrest and the start of cold storage. These kidney grafts often fail or are slow to function. Repairing such kidneys before transplant could greatly increase the available supply.

Kidneys donated after circulatory death are especially susceptible to injury due to low temperatures and lack of oxygen in conventional storage methods, such as static cold storage. An improved method, normothermic ex vivo kidney perfusion, or NEVKP, preserves kidneys at normal physiological temperature with nutrient and oxygen flow. NEVKP shows promise at improving kidney transplant function, but researchers do not know the molecular basis for this improvement yet.

In a new paper in the journal Molecular & Cellular Proteomics, Caitriona McEvoy and colleagues at the University of Toronto describe using pig models of donation after circulatory death to compare global protein expression in transplanted kidneys after NEVKP and static cold storage. Using mass spectrometry and pathway analysis, they found that NEVKP increased expression of proteins linked to mitochondrial metabolism while it decreased markers of kidney injury. They propose that peroxisome proliferator–activated receptors, or PPARs, are master regulators of these effects. These findings suggest therapeutic targets for improving kidney transplant outcomes.

 

Mannose glycosylation linked to eye development

An unusual type of protein glycosylation, C-mannosylation, involves attaching a single mannose sugar to the amino acid tryptophan by a carbon–carbon bond. C-mannosylation, which regulates protein secretion, folding and function, occurs at a specific sequence of four amino acids that begins with the modified tryptophan. Even though about 18% of secreted or transmembrane proteins have this sequence, few studies have looked for the modification. Consequently, researchers know of few proteins that are C-mannosylated.

In a new study in the journal Molecular & Cellular Proteomics, Karsten Cirksena of the Institute of Clinical Biochemistry and a team of researchers in Germany found numerous proteins with altered secretion levels in cells lacking the C-mannosylation machinery. One of these potentially C-mannosylated proteins, a disintegrin and metalloprotease with thrombospondin motifs, or ADAMTS16, is essential during eye development and optic fissure closure. In Chinese hamster ovary cells and Japanese rice fish, the researchers demonstrated that ADAMTS16 can be C-mannosylated, that its secretion depends on C-mannosylation and that loss of a C-mannosylation enzyme causes a developmental eye defect known as a partial coloboma — a gap in the eye tissue. Their findings suggest that C-mannosylation, an understudied protein modification, plays a critical role in eye development by regulating secretion of ADAMTS16.

Sarah May

Sarah May holds a Ph.D. in biochemistry from the Medical College of Wisconsin in Milwaukee, where she is now a postdoctoral fellow.

Join the ASBMB Today mailing list

Sign up to get updates on articles, interviews and events.

Latest in Science

Science highlights or most popular articles

Finding the right research path
Interview

Finding the right research path

Sept. 16, 2021

Karen Bornfeldt, an associate editor for the Journal of Lipid Research, investigates how diabetes increases cardiovascular disease risk.

From the journals: JBC
Journal News

From the journals: JBC

Sept. 15, 2021

Antibody interactions that change cytotoxicity. An atlas for macrophage activation. Anti–Zika virus natural products. Read about papers on these and other topics.

Noboru Sueoka (1929 – 2021)
Retrospective

Noboru Sueoka (1929 – 2021)

Sept. 13, 2021

Sueoka made widely known contributions to our understanding of DNA replication. Indeed, he coined the term “origin of replication.”

From CRISPR to glowing proteins to optogenetics
Feature

From CRISPR to glowing proteins to optogenetics

Sept. 12, 2021

Three pioneering technologies have forever altered how researchers do their work and promise to revolutionize medicine, from correcting genetic disorders to treating degenerative brain diseases.

Lobsters hold the secret of a long, cancer-free life in their genes
News

Lobsters hold the secret of a long, cancer-free life in their genes

Sept. 11, 2021

More than a mere delicacy, the humble lobster could teach us a lot about healthy aging.

Personal chemistry: Proteomics tackles privacy concerns
Feature

Personal chemistry: Proteomics tackles privacy concerns

Sept. 9, 2021

Sharing raw data is an important norm for the proteomics community. But as clinical studies become more detailed, researchers may need to clamp down to protect patient privacy.